"Buzz on the Street" Show: NewLeaf Brands (CSE: NLB) (OTC: NLBIF) We Are Kured Signs LOI with DPAC | Financial Buzz

“Buzz on the Street” Show: NewLeaf Brands (CSE: NLB) (OTC: NLBIF) We Are Kured Signs LOI with DPAC

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “NewLeaf Brands’ Wholly Owned Subsidiary We Are Kured, LLC Signs LOI to Enter Colorado Cannabis Industry.”

NewLeaf Brands Inc.’s (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) wholly owned subsidiary We Are Kured, LLC,  announces that it has entered into a letter of intent with Denver based marijuana infused product license holder, Denver Packaging Company, to enter the Colorado cannabis market in 2020.  DPAC is the license holder that manufactures renowned brands such as Keef Cola, Keef Pax Pods and Oil Sticks. Under the terms of the LOI, DPAC will commit to all licensing, manufacturing and distribution of Kured products and Kured will cover the cost of all goods, as well as provide marketing and sales force and sales management on behalf of DPAC. Further, Kured will introduce an ultra-high quality THC version of its flagship 500mg custom disposable vaporizer line that includes the Eybana terpene profiles and subsequent cartridges. According to newfrontierdata.com, the legal marijuana market in the state of Colorado, USA is expected to exceed $2,000,000 in revenue in 2020.1

NewLeaf Brands, Inc. is an innovative Cannabidiol lifestyle Company. Through the Company’s wholly-owned subsidiaries We are Kured, LLC, Drink Fresh Water, LLC, ReLyfe Brand, LLC and TeaLief Brand, LLC the Company’s main business activities encompass the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, softgel capsules and beverages) throughout North America, South America, and Europe. In addition, NewLeaf Brands, Inc. has extensive retail and cultivation land investments in Oregon, USA.

The evolution of the cannabis industry has introduced new products into the marketplace, causing the sales and market share of flower to dwindle. Normally, most people associate cannabis with its counter-culture, smoking stereotype. However, as the legal cannabis industry continues to progress, innovative producers have begun to develop alternative methods to consume cannabis. Notably, cannabis-based oils have become widely popular because of their potent and immediate effects. Additionally, consumers tend to believe that oils were a healthier alternative to actually burning cannabis. Now, CBD-based oils are expected to witness immense growth due to the ongoing, global legislative movements. Overall, CBD is having a major impact on global markets because it offers a number of therapeutic benefits without the psychoactive effects of THC. Consequently, many countries such as AustraliaCanadaChileDenmarkMexicoPortugal, and Thailand have all legalized CBD for medical applications. In particular, CBD is having a profound impact on the U.S. and Canadian markets because of their massive user base. Moreover, the U.S. and Canada have legalized CBD entirely, which prompted many retailers to add CBD products to their shelves. In the North American region, CBD is much more prevalent for treating minor medical conditions like soreness or headaches. Additionally, North American consumers are purchasing CBD-based products for health and wellness purposes. On the other hand, international marketplaces are looking to use CBD to treat severe medical illnesses such as infectious and chronic diseases. Notably, the rise in healthcare expenditures, as well as the growing awareness about the therapeutic benefits of CBD, are expected to propel the overall industry’s growth. And according to data compiled by Transparency Market Research, the global CBD hemp oil market is expected to reach USD 2.5 Billion by 2026 while exhibiting a CAGR of more than 11% throughout the forecast period from 2018 to 2026. 

CBD is a compound found within the hemp plant, which falls under the cannabis family. Similarly, the marijuana plant is also found under the cannabis family, however, THC is its main active ingredient. And while cannabis is most commonly associated with its THC compound, which ultimately led regulators to deem the plant unsafe for consumers, more people are now beginning to understand that there is more to the plant. Over the past several decades, researchers have studied the plant to better understand its effects and disprove many previously conceived notions. Consequently, regulators in the U.S. and Canada decided to remove CBD from the controlled substances list and now the CBD market is expected to experience a sharp rise in demand due to the growing global prevalence of chronic and infectious diseases. Moreover, CBD is known to reduce acne, relieve pain and cancer-related symptoms, as well as reduce depression and anxiety and is expected to have a larger impact on younger consumers because they are much more susceptible to sleep disorders and depression. Generally, the human body already produces certain cannabinoids on its own and has two receptors for cannabinoids: CB1 and CB2 receptors. CB1 receptors are more prevalent in the brain, but CB2 receptors are present throughout the whole immune system. CB1 receptors deal with coordination and movement, pain, emotions, mood, appetite, and memory. On the other hand, CB2 receptors affect inflammation and pain, according to a post by Medical News Today, which was reviewed by Debra Rose Wilson, PhD, MSN, RN, IBCLC, AHN-BC, CHT. Originally, researchers believed that CBD attached to these receptors to produce effects in the body. However, it is now believed that CBD instead directs the body to use more of its own cannabinoids. As such, CBD promises a wide range of medical solutions for minor illnesses as well as severe conditions. And as a result, industry experts believe that CBD will become a versatile and innovative treatment within the healthcare sector. “CBD is the next healthcare phenomenon. It is so effective for so many conditions, is natural, non-psychoactive and has no known serious side effects,” said Bethany Gomez, Managing Director at Brightfield Group.

For more information, please visit: NewLeaf Brands, Inc.

For more corporate news on NewLeaf Brands, Inc., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

2 Comments
  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For newleaf brands inc., financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.